
Anthony Colenburg
Associate Director of Quality, Lonza Biologics, USA
When
3rd-4th Dec 2019
Where
Singapore
Hotel Fort Canning
“Our investment in digital manufacturing operations and processes will allow us to ensure efficient and high-quality production of our medicines.”
Spokesperson leading pharmaceutical organisation
The advent of Pharma 4.0 is set to bring about a transformation of the manufacturing process. Its supporters believe that it will enable firms to become more agile and efficient as they meet new challenges in drug discovery and compliance.
Described by some as the 4th industrial revolution, Pharma 4.0 aims to bring the internet of things, artificial intelligence, automation and smart technology to the manufacturing floor. By digitising machines and processes, Pharma 4.0 will break down silos and drive forward developments in continuous manufacturing. With benefits such as lower operational costs, efficient production lines, consistent quality, reduced processing time and lower manual handling, it is no wonder that pharma companies are investing heavily in new technology.
Attracting experts from the pharma and biopharma industry working in the areas of manufacturing, operation and regulation, this two-day congress will offer you an exceptional opportunity to take home all the cutting developments in this field.
This congress has been designed to create a collaborative environment in which you can engage with the speakers, sponsors and other delegates in attendance.